Resources
About Us
Showing 1-8
The North America NGS Market is expected to reach $13.7 billion by 2032, at a CAGR of 16% from 2025–2032. The growth of the North America NGS market is mainly attributed to the rising prevalence of cancer, the increasing utilization of NGS in cancer research ...
The Asia-Pacific Next Generation Sequencing (NGS) Market is expected to grow at a CAGR of 16.9% from 2025 to 2032 to reach $6.38 billion by 2032. Next Generation Sequencing (NGS) is a technology used to sequence the orientation of nucleotides in genetic material. ...
The Europe NGS Market is expected to grow at a CAGR of 14.8% from 2025 to 2032 to reach $6.40 billion by 2032. The field of genomics has surpassed expectations over the past three decades due to massive changes in technology that allowed researchers to interrogate ...
The DNA Sequencing Market was valued at $9.14 billion in 2023. This market is expected to reach $21.30 billion by 2031, from an estimated $9.78 billion in 2024, at a CAGR of 11.8% during the forecast period 2024-2031. DNA Sequencing Market Size & Forecast Key ...
Next Generation Sequencing Services Market Size & Forecast The Next Generation Sequencing Services Market is expected to register a CAGR of 19.8% from 2024 to 2031 to reach $24.44 billion by 2031. The growth of this market is mainly driven by the declining costs ...
The Middle East & Africa NGS Market was valued at $155 million in 2024. This market is expected to reach $356.5 million by 2032, from an estimated $170.7 million in 2025, at a CAGR of 11.1% during the forecast period 2025-2032. Middle East & Africa NGS Market ...
The Latin America NGS Market was valued at $273.2 million in 2024. This market is expected to reach $765.2 million by 2032, from an estimated $307.7 million in 2025, at a CAGR of 13.9% during the forecast period 2025-2032. Latin America NGS Market Size & Forecast The ...
The Next Generation Sequencing (NGS) Market is expected to reach $27.5 billion by 2030, at a CAGR of 15.8% from 2023–2030. The growth of the NGS market is mainly attributed to increasing cancer prevalence & increasing application of NGS in cancer treatment ...
Showing 1-8